PBI Reports 49-Percent Rise in Q2 Revenues, Plans to Focus on Mass-Spec Sample Prep
August 20, 2010
PBI Reports 49-Percent Rise in Q2 Revenues, Plans to Focus on Mass-Spec Sample Prep
"The number of customers using our PCT platform in the workflow for mass spectrometry has increased dramatically in the last year, and so we're addressing that market particularly," said PBI's CEO.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Pressure BioSciences Aims to Raise $5M to Regain Compliance with Nasdaq Listing Requirements
June 17, 2011 / ProteoMonitor - Pressure BioSciences Signs R&D Agreement with the AFIP, ARM, VA for FFPE Protein Extraction
May 28, 2010 / ProteoMonitor - Pressure BioSciences Blames Snow Storms for Drop in Q1 Revenues
May 21, 2010 / ProteoMonitor - Pressure BioSciences Q2 Revenues Plunge 53 Percent; Enough Capital to Last until Mid-September
August 16, 2011 / GenomeWeb Daily News - PBI Hoping Revenue Rebound, Exercise of Warrants Will Lead to Additional Staffing
April 2, 2010 / ProteoMonitor